Dai Nippon Printing Co., Ltd. Overview
Dai Nippon Printing is Japan's second-largest printing group by revenue, after TOPPAN Holdings. Over 150 years it has turned the core skills of printing (fine patterning, precision coating, lamination and secure handling of information) into a diversified manufacturing and services business. DNP calls this capability "P&I", for Printing and Information. FY2025 net sales were ¥1.51 trillion. The group has three segments. Smart Communication covers secure IC cards, BPO, photo-imaging media, publishing and marketing. Life & Healthcare covers packaging, building materials, battery pouches, solar encapsulants, pharmaceuticals and the Hokkaido Coca-Cola bottler. Electronics covers semiconductor photomasks, OLED metal masks and display optical films. Electronics earns half of segment profit on about one-sixth of sales. DNP is one of the world's largest merchant photomask suppliers and a strategic partner to Japan's national 2nm foundry project, Rapidus. It is also building positions in nanoimprint templates for Canon's lithography tools and in glass-core substrates for AI-chip packaging. Since activist pressure in 2023, DNP has paired portfolio reform with heavy buybacks and now targets ¥130bn operating profit and a 10% ROE by FY2028.
What the company does
DNP turns microfabrication, coating, information-processing and secure-handling capabilities into products and services for a wide range of end markets. At one end are commoditised printed matter, such as magazines, catalogues and commercial print. At the other are some of the most technically demanding consumables in electronics: EUV photomasks, nanoimprint templates and fine metal masks that pattern OLED pixels. The group describes this as "P&I Innovation", meaning new value created by combining printing technology with information technology.
The business model is mainly business-to-business manufacturing and services. Most revenue comes from making physical products to customer specifications: masks, films, cards, packaging, printed matter and pharmaceutical ingredients. A growing share comes from services, including business process outsourcing (BPO), contact centres, card personalisation, data management, digital marketing, library services and education platforms. The Hokkaido Coca-Cola Bottling subsidiary adds consumer revenue from beverages. Licensing and subscriptions are small and are not reported separately.
The company's own description
In its latest results and medium-term plan materials, DNP describes itself as a company that creates "products and services that become the norm of the future" by pursuing P&I Innovation. Its corporate tagline is 「未来のあたりまえをつくる。」 ("Creating the future's everyday"). It names focus business areas in each segment where it concentrates investment. These include Information Security, Photo Imaging, Mobility (battery pouches and related materials), Medical & Healthcare, Digital Interface (displays) and Semiconductors. The remaining businesses are classed as "stable" or "for reforming" and are managed for cash generation and restructuring.
Independent characterisation
DNP is best read as a portfolio of three different businesses.
-
A high-margin precision electronics materials business. Photomasks, nanoimprint templates, OLED metal masks and optical films earned ¥50.7bn of operating profit in FY2025 at a 20.1% margin. This business is technically differentiated and has few competitors. It is exposed to the semiconductor and display capex cycles, and it drives most of DNP's equity story.
-
A mid-margin secure-information and imaging franchise. IC payment and ID cards, BPO and dye-sublimation photo media sit alongside a large, structurally declining domestic print and publishing base. This is being restructured.
-
A low-to-mid-margin materials and consumer business. Packaging, interior and building materials, battery pouches, solar encapsulants, pharmaceutical APIs and beverages. Restructuring has lifted this segment's margin from 2.8% to 7.3% in two years.
The investment case rests on whether the group can move profit toward the first category faster than the print base declines, while continuing to return surplus capital.
Value-chain position, customers and end markets
| Business area | Value-chain position | Customer types | End markets |
|---|---|---|---|
| Semiconductor photomasks and nanoimprint templates | Tier-1 consumable supplier to wafer fabs and lithography tool makers | Foundries, IDMs, memory makers, Rapidus, Canon (nanoimprint) | Logic, memory, power, MEMS |
| Glass-core substrates (TGV) | Advanced packaging materials | Substrate makers, OSATs, chip designers | AI and data-centre packaging |
| OLED metal masks and optical films | Component supplier to panel makers | OLED and LCD panel makers | Smartphones, IT, TV, automotive displays |
| IC cards, BPO, security printing | Manufacturer and service operator | Banks, card schemes, telecoms, governments, insurers | Payments, identity, telecoms, public sector |
| Photo-imaging media | Consumables and printer OEM | Photo retailers, kiosks, event photographers | Consumer photo, ID photo |
| Publishing, commercial print, bookstores, library services | Printer, distributor, retailer | Publishers, retailers, municipalities, libraries | Publishing, retail, education |
| Packaging | Converter and system supplier | Food, beverage, personal care and pharmaceutical brand owners | Consumer staples |
| Battery pouches, solar encapsulants | Materials supplier | Battery cell makers, PV module makers | IT devices, EVs, renewables |
| Pharmaceuticals (API, formulation, packaging) | CDMO and API maker | Pharmaceutical companies | Generic and new drugs |
| Beverages | Bottler (Coca-Cola system) | Retailers, vending | Hokkaido consumer market |
Semiconductor photomasks and nanoimprint templates: Value-chain position: Tier-1 consumable supplier to wafer fabs and lithography tool makers; Customer types: Foundries, IDMs, memory makers, Rapidus, Canon (nanoimprint); End markets: Logic, memory, power, MEMS
Glass-core substrates (TGV): Value-chain position: Advanced packaging materials; Customer types: Substrate makers, OSATs, chip designers; End markets: AI and data-centre packaging
OLED metal masks and optical films: Value-chain position: Component supplier to panel makers; Customer types: OLED and LCD panel makers; End markets: Smartphones, IT, TV, automotive displays
IC cards, BPO, security printing: Value-chain position: Manufacturer and service operator; Customer types: Banks, card schemes, telecoms, governments, insurers; End markets: Payments, identity, telecoms, public sector
Photo-imaging media: Value-chain position: Consumables and printer OEM; Customer types: Photo retailers, kiosks, event photographers; End markets: Consumer photo, ID photo
Publishing, commercial print, bookstores, library services: Value-chain position: Printer, distributor, retailer; Customer types: Publishers, retailers, municipalities, libraries; End markets: Publishing, retail, education
Packaging: Value-chain position: Converter and system supplier; Customer types: Food, beverage, personal care and pharmaceutical brand owners; End markets: Consumer staples
Battery pouches, solar encapsulants: Value-chain position: Materials supplier; Customer types: Battery cell makers, PV module makers; End markets: IT devices, EVs, renewables
Pharmaceuticals (API, formulation, packaging): Value-chain position: CDMO and API maker; Customer types: Pharmaceutical companies; End markets: Generic and new drugs
Beverages: Value-chain position: Bottler (Coca-Cola system); Customer types: Retailers, vending; End markets: Hokkaido consumer market
Strategy
Strategic framework
| Step | Period | Theme | Operating profit | ROE |
|---|---|---|---|---|
| Step 1 | FY2023–FY2025 | Expand focus businesses and push structural reform | ¥61.2bn rising to ¥101.0bn | 7.9% rising to 8.9% |
| Step 2 | FY2026–FY2028 | Deepen P&I Innovation and invest aggressively in focus businesses | ¥130bn | 10% (9% excluding special items) |
| Step 3 | FY2029–FY2031 | Further growth through innovation | ¥150bn or more | 10% or more on a core basis |
DNP's strategy follows the basic management policy adopted in February 2023: target a 10% ROE, keep P/B above 1x, and allocate capital between growth investment and shareholder returns. The company presents its path as three steps:
Step 1: Period: FY2023–FY2025; Theme: Expand focus businesses and push structural reform; Operating profit: ¥61.2bn rising to ¥101.0bn; ROE: 7.9% rising to 8.9%
Step 2: Period: FY2026–FY2028; Theme: Deepen P&I Innovation and invest aggressively in focus businesses; Operating profit: ¥130bn; ROE: 10% (9% excluding special items)
Step 3: Period: FY2029–FY2031; Theme: Further growth through innovation; Operating profit: ¥150bn or more; ROE: 10% or more on a core basis
FY2026–FY2028 Medium-Term Management Plan (finalised 13 May 2026)
| Pillar | Key commitments |
|---|---|
| Business strategy | Grow operating profit at about a 9% CAGR to ¥130bn in FY2028, above the FY2005 record of ¥120.6bn. Electronics to ¥65bn, Smart Communication to ¥50bn, Life & Healthcare to ¥46bn |
| Growth investment | ¥300bn or more of growth investment. About ¥300bn of capex over three years, including about ¥30bn for semiconductor photomasks. EUV photomask and NIL template mass production, glass-core mass-production lines |
| R&D | About ¥120bn cumulative over three years |
| Human capital | About ¥35bn cumulative. Female managers at 14% by FY2028 (15% by FY2030). Engagement targets |
| Environment | ¥10bn cumulative. Scope 1+2 GHG emissions down 37.8% versus FY2019 by FY2028 (−46.2% by FY2030). Eco-friendly product sales at 24.9% of sales by FY2028 (30% by FY2030) |
| Financial strategy | Operating cash flow of at least ¥510bn over three years. Equity ratio around 55%. Policy shareholdings below 10% of net assets |
| Shareholder returns | Buybacks of ¥50bn in FY2026 and at least ¥30bn in FY2027, completing the ¥300bn programme from 2023. Minimum DPS of ¥40, progressive dividends, payout ratio rising on profit excluding special items. FY2026 DPS planned at ¥41 |
| Structural reform | Over ¥26.5bn of cumulative operating profit benefit versus FY2022 from FY2026 onward |
| AI | "AI-native" operations, plus an external AI business service launched October 2026 targeting 500 client companies by FY2028 |
Business strategy: Key commitments: Grow operating profit at about a 9% CAGR to ¥130bn in FY2028, above the FY2005 record of ¥120.6bn. Electronics to ¥65bn, Smart Communication to ¥50bn, Life & Healthcare to ¥46bn
Growth investment: Key commitments: ¥300bn or more of growth investment. About ¥300bn of capex over three years, including about ¥30bn for semiconductor photomasks. EUV photomask and NIL template mass production, glass-core mass-production lines
R&D: Key commitments: About ¥120bn cumulative over three years
Human capital: Key commitments: About ¥35bn cumulative. Female managers at 14% by FY2028 (15% by FY2030). Engagement targets
Environment: Key commitments: ¥10bn cumulative. Scope 1+2 GHG emissions down 37.8% versus FY2019 by FY2028 (−46.2% by FY2030). Eco-friendly product sales at 24.9% of sales by FY2028 (30% by FY2030)
Financial strategy: Key commitments: Operating cash flow of at least ¥510bn over three years. Equity ratio around 55%. Policy shareholdings below 10% of net assets
Shareholder returns: Key commitments: Buybacks of ¥50bn in FY2026 and at least ¥30bn in FY2027, completing the ¥300bn programme from 2023. Minimum DPS of ¥40, progressive dividends, payout ratio rising on profit excluding special items. FY2026 DPS planned at ¥41
Structural reform: Key commitments: Over ¥26.5bn of cumulative operating profit benefit versus FY2022 from FY2026 onward
AI: Key commitments: "AI-native" operations, plus an external AI business service launched October 2026 targeting 500 client companies by FY2028
Initiatives announced in the last 24 months
| Date | Initiative | Detail |
|---|---|---|
| FY2024 | Photomask capacity | DT Fine Electronics line expansion. Second and third MBMW tools brought online |
| FY2024 | Shinko Electric | Investment in the acquisition vehicle that took Shinko Electric Industries (IC substrates) private |
| Apr 2025 | ¥100bn bond issue | Five-year ¥40bn, seven-year ¥20bn and ten-year ¥40bn tranches to fund growth and returns |
| FY2025 | Kamifukuoka photomask expansion | Added photomask capacity |
| Oct 2025 | Solar encapsulant capacity | Izumizaki line roughly doubles output |
| FY2025 | Gen-8 FMM line | Kurosaki Plant large-format OLED mask line, more than double previous capacity |
| Dec 2025 | TGV glass-core pilot line | Kuki Plant. Samples from early 2026. Mass-production structure targeted for FY2028 |
| Dec 2025 | 1.4nm NIL templates | Mass production for Canon NIL tools from 2027 |
| Feb 2026 | Rapidus investment | Participation in funding round to support 2nm mass production in 2027 |
| Mar–May 2026 | New medium-term plan | Outline in March, finalised in May |
| May 2026 | AUSTRIACARD offer | €10/share cash offer. 96.55% tendered by August 2026 |
| Jul–Oct 2026 | Kyowa Pharma Chemical | Acquired 100% to build a one-stop pharmaceutical CDMO |
| Oct 2026 | AI business service | External generative-AI service; 500-company target |
| Oct 2026 | Group reorganisation | Absorption of DNP Digital Solutions. Transfer of DNP Planning Network's sales division (April 2027) |
| 22 Oct 2026 | Sustainability investor briefing | Detailed ¥35bn human-capital, ¥120bn R&D and ¥10bn environmental commitments, plus stronger board oversight |
FY2024: Initiative: Photomask capacity; Detail: DT Fine Electronics line expansion. Second and third MBMW tools brought online
FY2024: Initiative: Shinko Electric; Detail: Investment in the acquisition vehicle that took Shinko Electric Industries (IC substrates) private
Apr 2025: Initiative: ¥100bn bond issue; Detail: Five-year ¥40bn, seven-year ¥20bn and ten-year ¥40bn tranches to fund growth and returns
FY2025: Initiative: Kamifukuoka photomask expansion; Detail: Added photomask capacity
Oct 2025: Initiative: Solar encapsulant capacity; Detail: Izumizaki line roughly doubles output
FY2025: Initiative: Gen-8 FMM line; Detail: Kurosaki Plant large-format OLED mask line, more than double previous capacity
Dec 2025: Initiative: TGV glass-core pilot line; Detail: Kuki Plant. Samples from early 2026. Mass-production structure targeted for FY2028
Dec 2025: Initiative: 1.4nm NIL templates; Detail: Mass production for Canon NIL tools from 2027
Feb 2026: Initiative: Rapidus investment; Detail: Participation in funding round to support 2nm mass production in 2027
Mar–May 2026: Initiative: New medium-term plan; Detail: Outline in March, finalised in May
May 2026: Initiative: AUSTRIACARD offer; Detail: €10/share cash offer. 96.55% tendered by August 2026
Jul–Oct 2026: Initiative: Kyowa Pharma Chemical; Detail: Acquired 100% to build a one-stop pharmaceutical CDMO
Oct 2026: Initiative: AI business service; Detail: External generative-AI service; 500-company target
Oct 2026: Initiative: Group reorganisation; Detail: Absorption of DNP Digital Solutions. Transfer of DNP Planning Network's sales division (April 2027)
22 Oct 2026: Initiative: Sustainability investor briefing; Detail: Detailed ¥35bn human-capital, ¥120bn R&D and ¥10bn environmental commitments, plus stronger board oversight
Management guidance (FY2026, year ending March 2027)
| Metric | FY2025 actual | FY2026 guidance | Change |
|---|---|---|---|
| Net sales (JPY bn) | 1,512.5 | 1,530.0 | 1.2% |
| Operating profit (JPY bn) | 101.0 | 108.0 | 6.9% |
| Operating margin (%) | 6.7 | 7.1 | 0.4pt |
| Ordinary profit (JPY bn) | 119.2 | 124.0 | 4.0% |
| Net profit (JPY bn) | 103.9 | 95.0 | -8.6% |
| EPS (JPY) | 235.49 | 224.24 | -4.8% |
| ROE (%) | 8.9 | 8.0 | -0.9pt |
| Capex (JPY bn) | 87.7 | 77.0 | -12.2% |
| R&D (JPY bn) | 42.2 | 43.0 | 1.7% |
| Depreciation (JPY bn) | 52.8 | 57.0 | 7.9% |
| DPS (JPY) | 40 | 41 | 1 |
Net sales (JPY bn): FY2025 actual: 1512.5; FY2026 guidance: 1530.0; Change: 1.2%
Operating profit (JPY bn): FY2025 actual: 101.0; FY2026 guidance: 108.0; Change: 6.9%
Operating margin (%): FY2025 actual: 6.7; FY2026 guidance: 7.1; Change: 0.4pt
Ordinary profit (JPY bn): FY2025 actual: 119.2; FY2026 guidance: 124.0; Change: 4.0%
Net profit (JPY bn): FY2025 actual: 103.9; FY2026 guidance: 95.0; Change: -8.6%
EPS (JPY): FY2025 actual: 235.49; FY2026 guidance: 224.24; Change: -4.8%
ROE (%): FY2025 actual: 8.9; FY2026 guidance: 8.0; Change: -0.9pt
Capex (JPY bn): FY2025 actual: 87.7; FY2026 guidance: 77.0; Change: -12.2%
R&D (JPY bn): FY2025 actual: 42.2; FY2026 guidance: 43.0; Change: 1.7%
Depreciation (JPY bn): FY2025 actual: 52.8; FY2026 guidance: 57.0; Change: 7.9%
DPS (JPY): FY2025 actual: 40; FY2026 guidance: 41; Change: 1
The FY2026 operating profit guidance includes a ¥10.2bn tailwind from lower retirement-benefit expense and an expected ¥2.0bn hit from the Middle East situation in Q1. Before the Middle East effect, the outlook was ¥110bn.
Products & Services
Electronics
| Product line | Description and capabilities | Target customers | Status / latest milestone |
|---|---|---|---|
| EUV photomasks (2nm generation and beyond) | Reflective masks for EUV logic patterning, written with multi-beam mask writers. Pellicle-compatible process under development | Rapidus and leading-edge logic fabs | 3nm process completed 2023. 2nm process development scheduled to finish in FY2025, production technology to be established from FY2026, mass production targeted for FY2027. Development toward 1.4nm under way |
| ArF/KrF and i-line photomasks | Optical masks for mature and mid-range nodes, made in Japan, Taiwan and Europe | Foundries, IDMs, memory, power and analog makers | Capacity expansions at DT Fine Electronics (FY2024) and the Kamifukuoka Plant (FY2025). About ¥30bn of photomask capex planned in the FY2026–FY2028 plan |
| Multi-beam mask writing (MBMW) | Writer tools that cut write times for complex masks | Internal capability | First merchant maker to adopt (2016). Second and third tools brought online in FY2024 |
| Nanoimprint lithography (NIL) templates | Master templates ("stamps") for Canon's NIL tools. 10nm line resolution shown in 2025. Template technology for the 1.4nm logic node announced in December 2025 | Canon and its NIL users (memory and logic makers) | Mass production targeted from 2027. NIL is reported to use about one-tenth of the energy of conventional patterning |
| Nanoimprint contract manufacturing | Mass production of nanoimprinted optical and other products through the Nanoimprint Solutions JV with SCIVAX | Optics and sensor makers | JV operating since April 2023 |
| TGV glass-core substrates | Through-glass-via core for FC-BGA packages on 510 × 515 mm panels. Flatness and rigidity reduce warpage in large chiplet packages | Substrate makers and AI-chip designers | Pilot line at the Kuki Plant since December 2025. Samples shipped from early 2026. Mass-production structure planned for FY2028 |
| OLED fine metal masks (FMM) | Ultra-thin metal masks for depositing red, green and blue OLED materials. New Gen-8 large-format line at the Kurosaki Plant has more than double the previous capacity | OLED panel makers (smartphone, IT) | Gen-8 line for IT-size OLED. Q1 FY2026 sales were hit by panel output cuts linked to the memory chip shortage |
| Optical films for displays | Anti-reflection, anti-glare and functional films. 2,500 mm wide coating line at the Mihara Plant | LCD and OLED panel makers (TV, monitor, automotive) | Wide-width line in operation |
| LCD colour filters | Legacy display component | Panel makers | Business for reforming |
| Vapor chambers and reflectarray antennas | Thin thermal-management parts for devices. Passive reflectors for 5G and next-generation communications | Device makers, telecom operators | Newer products |
Smart Communication
| Product line | Description | Target customers | Notes |
|---|---|---|---|
| Dye-sublimation thermal transfer ribbons and photo printers | Ribbons, media and compact photo printers sold through DNP Imagingcomm subsidiaries in the Americas, Europe and Asia | Photo retailers, kiosk operators, event and ID photo | FY2025 growth driven by media for new printer models in Europe and the US |
| Thermal transfer ribbons for barcodes | Wax and resin ribbons for labels | Logistics, retail, manufacturing | Part of Imaging Communication |
| ID photo booths and photo kiosks | Self-service photo terminals in Japan | Consumers, municipalities | Domestic installed base |
| IC cards (payment, transit, ID) | Contact, contactless and dual-interface cards, metal cards, eSIM/SIM, plus personalisation and issuance services | Banks, card brands, telecoms, public sector | Domestic volumes declined in FY2025. AUSTRIACARD would add European, African and North American card and ID capacity once FDI clearance is received |
| Citizen ID and security printing | Variable security printing, identity documents | Governments, financial institutions | Strengthened by AUSTRIACARD's citizen-identity business |
| BPO and contact centres | Outsourced document processing, back-office operations and campaign execution | Government, financial services, utilities | Large BPO projects lifted FY2025 sales |
| Information security / authentication services | eKYC, data security platforms, digital identity | Financial institutions, enterprises | Data-platform users reached 8,525 in FY2025, short of the 10,000 target |
| Marketing services | Commercial printing, digital marketing, promotions, retail media | Retailers, consumer brands | Stable/reform business |
| Content & XR communication | Virtual events, metaverse and "XR" spaces, IP and content businesses | Brands, municipalities, media | Focus business |
| Publishing printing and distribution | Magazine, book and e-book production. Maruzen Junkudo bookstores. honto e-commerce. TRC library services | Publishers, libraries, consumers | Publishing Printing Division under structural reform. The Kuki Plant, a former publication-printing site, has been repurposed for glass-core substrates |
| Education | School ICT, digital textbooks and learning platforms | Schools, education boards | Part of Smart Communication |
| AI-native business services | Generative-AI-based service launched October 2026 | Enterprises | Target of 500 client companies by FY2028 |
Life & Healthcare
| Product line | Description | Target customers | Notes |
|---|---|---|---|
| Flexible and rigid packaging | Films, pouches, labels, cartons and tubes, including mono-material and recycled-content designs | Food, beverage, toiletry and pharmaceutical brand owners | Price revisions and higher-value mix supported FY2025 profit |
| Transparent barrier films ("IB-Film") | Vapour-deposited barrier films that replace aluminium foil | Food and pharmaceutical packagers | Supports eco-friendly product sales (17.3% of sales in FY2025) |
| Aseptic PET bottle filling systems | Turnkey sterile filling lines | Beverage bottlers | Engineering and system sales |
| Interior and exterior decorative materials | Printed decorative sheets for housing and furniture, including electron-beam-cured surfaces | Housing, building and furniture makers | Living Space business |
| Lithium-ion battery pouches | Aluminium-laminate soft-pack battery packaging | Cell makers for IT devices and EVs | Focus (Mobility) business. Sales rose for IT applications in FY2025 but fell in Q1 FY2026 because of memory-shortage effects on device builds |
| Solar cell encapsulants | Encapsulant sheets for PV modules. Izumizaki Plant (Fukushima) line with about double the previous capacity started October 2025 | PV module makers | Mobility & Industrial materials |
| Automotive decorative and functional films | Interior trim and functional films | Automotive OEMs and tier suppliers | Mobility |
| APIs (active pharmaceutical ingredients) | Generic APIs at DNP Fine Chemicals Utsunomiya. New-drug APIs such as tranexamic acid and prostaglandins at Kyowa Pharma Chemical | Pharmaceutical companies | Kyowa Pharma Chemical consolidated from 1 October 2026 |
| Formulation CDMO | Contract development and manufacture of formulations at CMIC CMO | Pharmaceutical companies | Part of a one-stop chain from API to formulation to packaging |
| Pharmaceutical and medical packaging | Blister, pouch and labelling solutions | Pharmaceutical companies | Medical & Healthcare focus area |
| Beverages | Coca-Cola system products in Hokkaido via Hokkaido Coca-Cola Bottling | Retailers, vending, consumers | Price revisions and higher mass-retail sales lifted FY2025 profit |
Pricing models are not publicly disclosed for any product line. Products are sold under negotiated B2B contracts, with services billed per transaction or per project.
Financial Narrative
Sources: DNP annual results releases (Kessan Tanshin) for FY2021–FY2025; FY2025 results presentation. Figures in ¥bn unless stated.
Margins and growth
Revenue CAGR, FY2021–FY2025: 3.0%. Operating profit CAGR over the same period: 10.9%.
DNP's gross profit is in its securities report, but its summary results only highlight operating figures. Selling, general and administrative (SG&A) expenses were about ¥245bn in FY2024, which implies a gross margin of about 23%.
Commentary. Sales have risen for five consecutive years. Operating profit inflected in FY2023 and FY2024 (+23.2% and +24.1%), when the structural reforms of the 2023 plan started to show. Management puts the cumulative profit benefit of those reforms at ¥21.5bn by FY2025 and over ¥26.5bn from FY2026. Net profit has run above operating profit since FY2021 because of large gains on sales of cross-held shares and equity-method income (¥12.6bn in FY2025). This explains why net profit fell 6.1% in FY2025 while operating profit rose 7.9%, and why the company guides net profit down a further 8.6% to ¥95bn in FY2026 as these gains taper. FY2024 included a Q4 net loss of ¥5.4bn tied to restructuring charges. Ordinary profit benefits from dividend income on a large securities portfolio (¥369.5bn of investment securities at March 2026).
Balance sheet (at 31 March)
DNP has a net cash balance sheet, so net debt/EBITDA is negative. Short-term debt was ¥39.6bn and long-term debt ¥224.0bn (including bonds) at March 2026. DNP also holds ¥369.5bn of listed and unlisted investment securities, which management plans to cut below 10% of consolidated net assets.
Cash flow
Commentary. Cash flow is lumpy. FY2023 investing cash flow was positive because cross-shareholding sales exceeded capex. FY2025 operating cash flow fell from ¥132.7bn to ¥40.4bn, which left free cash flow after capex negative. DNP funded the gap, buybacks and the move into Rapidus and other investments through the ¥100bn bond issue of April 2025. Financing cash flow turned positive for the first time in the period, and cash and equivalents ended slightly lower at ¥243.6bn. Operating cash flow conversion is the most important metric to monitor in FY2026. The plan assumes operating cash flow of at least ¥510bn over FY2026–FY2028 before R&D and human-capital spending.
Key ratios
ROIC, interest coverage and the cash conversion cycle are not publicly disclosed by DNP. Interest expense is immaterial relative to operating profit given the net cash position.
Trend summary. DNP met or beat every operating profit and ROE target in its 2023–2025 plan. Operating profit reached ¥75.4bn, ¥93.6bn and ¥101.0bn against targets of ¥67bn, ¥75bn and ¥85bn. ROE stayed at or above the 8% floor. P/B rose from 0.9x (March 2023) to about 1.1–1.2x (early 2026). ROE excluding special gains is lower: 7.3% in FY2025 against 5.6% in FY2022. Lifting core ROE toward 10% depends on operating profit growth rather than asset sales.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Segment Overview
| Segment | Contents | Key businesses |
|---|---|---|
Smart Communication | Information-related printing, secure information processing and imaging | Imaging Communication (photo media and printers); Information Security (IC cards, BPO, security printing); Content & XR Communication; Marketing; Publishing printing; Education; bookstores and library services |
Life & Healthcare | Packaging, interior and building materials, industrial high-performance materials, medical and healthcare, beverages | Packaging; Living Space (decorative materials); Mobility & Industrial High-Performance Materials (battery pouches, solar encapsulants); Medical & Healthcare (APIs, formulations, pharmaceutical packaging); Beverages (Hokkaido Coca-Cola Bottling) |
Electronics | Display and semiconductor components | Digital Interface (OLED metal masks, optical films, colour filters); Semiconductors (photomasks, nanoimprint templates, TGV glass-core substrates, other precision parts) |
Revenue by Segment
| Segment | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Smart Communication sales (JPY Bn) | 719.4 | 715.5 | 750.3 |
Life & Healthcare sales (JPY Bn) | 472.3 | 496.0 | 512.3 |
Electronics sales (JPY Bn) | 235.3 | 247.7 | 251.8 |
Adjustments sales (JPY Bn) | -2.2 | -1.7 | -1.9 |
Total net sales (JPY Bn) | 1,424.8 | 1,457.6 | 1,512.5 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansRevenue by Segment — Smart Communication OP
| Segment | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Smart Communication OP (JPY Bn) | 26.1 | 34.6 | 40.0 |
Life & Healthcare OP (JPY Bn) | 13.3 | 23.7 | 37.2 |
Electronics OP (JPY Bn) | 58.1 | 57.3 | 50.7 |
Adjustments OP (JPY Bn) | -22.1 | -22.2 | -26.9 |
Total operating profit (JPY Bn) | 75.4 | 93.6 | 101.0 |
Segment Margins & Growth (%) and Revenue by Segment (%)
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Smart Communication OP margin (%) | 3.6 | 4.8 | 5.3 |
Life & Healthcare OP margin (%) | 2.8 | 4.8 | 7.3 |
Electronics OP margin (%) | 24.7 | 23.1 | 20.1 |
Smart Communication sales YoY (%) | — | -0.5 | 4.9 |
Life & Healthcare sales YoY (%) | — | 5.0 | 3.3 |
Electronics sales YoY (%) | — | 5.3 | 1.6 |
Smart Communication share of sales (%) | 50.5 | 49.1 | 49.6 |
Life & Healthcare share of sales (%) | 33.2 | 34.0 | 33.9 |
Electronics share of sales (%) | 16.5 | 17.0 | 16.6 |
Revenue by Segment (FY2025 actual–FY2028 plan)
| Segment | FY2025 actual | FY2026 plan | FY2027 plan | FY2028 plan |
|---|---|---|---|---|
Smart Communication OP (JPY Bn) | 40.0 | 43 | 47 | 50 |
Life & Healthcare OP (JPY Bn) | 37.2 | 39 | 43 | 46 |
Electronics OP (JPY Bn) | 50.7 | 54 | 59 | 65 |
Adjustments OP (JPY Bn) | -26.9 | -28 | -29 | -31 |
Total OP (JPY Bn) | 101.0 | 108 | 120 | 130 |
Income Statement and Per-Share Data
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Net sales (JPY Bn) | 1,344.1 | 1,373.2 | 1,424.8 | 1,457.6 | 1,512.6 |
Operating profit (JPY Bn) | 66.8 | 61.2 | 75.5 | 93.6 | 101.0 |
Ordinary profit (JPY Bn) | 81.2 | 83.7 | 98.7 | 115.9 | 119.2 |
Net profit attributable to owners (JPY Bn) | 97.2 | 85.7 | 110.9 | 110.7 | 104.0 |
Depreciation (JPY Bn) | — | — | 56.0 | 53.7 | 52.8 |
EBITDA, OP plus depreciation (JPY Bn) | — | — | 131.5 | 147.3 | 153.8 |
Basic EPS (JPY, split-adjusted) | 177.92 | 160.66 | 221.56 | 238.90 | 235.49 |
Diluted EPS (JPY, split-adjusted) | — | — | — | 238.88 | 235.45 |
Dividend per share (JPY, split-adjusted) | 32 | 32 | 32 | 38 | 40 |
Payout ratio (%) | 18.0 | 19.9 | 14.4 | 15.9 | 17.0 |
Margin Analysis (%)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Sales growth (%) | 0.7 | 2.2 | 3.8 | 2.3 | 3.8 |
Operating margin (%) | 4.97 | 4.46 | 5.30 | 6.42 | 6.68 |
Ordinary margin (%) | 6.04 | 6.09 | 6.93 | 7.95 | 7.88 |
Net margin (%) | 7.23 | 6.24 | 7.79 | 7.59 | 6.87 |
EBITDA margin (%) | — | — | 9.23 | 10.11 | 10.17 |
Balance Sheet and Margin Analysis (%)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Total assets (JPY Bn) | 1,876.6 | 1,830.4 | 1,955.6 | 1,917.8 | 2,034.1 |
Shareholders' equity (JPY Bn) | 1,091.9 | 1,087.5 | 1,165.9 | 1,135.8 | 1,190.5 |
Net assets incl. minorities (JPY Bn) | 1,148.4 | — | 1,236.7 | 1,208.8 | 1,267.1 |
Equity ratio (%) | 58.2 | 59.4 | 59.6 | 59.2 | 58.5 |
Cash and deposits (JPY Bn) | — | — | 228.8 | 255.0 | 298.1 |
Cash and equivalents, CF basis (JPY Bn) | 293.4 | 258.3 | 234.6 | 250.6 | 243.6 |
Short-term borrowings (JPY Bn) | — | — | 38.3 | 31.7 | 33.0 |
Current portion of long-term borrowings (JPY Bn) | — | — | 4.5 | 5.8 | 6.6 |
Long-term borrowings (JPY Bn) | — | — | 23.4 | 24.4 | 24.0 |
Bonds (JPY Bn) | — | — | 100.0 | 100.0 | 200.0 |
Total interest-bearing debt (JPY Bn) | — | — | 166.2 | 161.9 | 263.6 |
Net cash, cash and deposits minus debt (JPY Bn) | — | — | 62.6 | 93.1 | 34.5 |
Goodwill (JPY Bn) | — | — | 4.1 | 10.3 | 30.6 |
Total intangible assets incl. goodwill (JPY Bn) | — | — | 30.7 | 46.4 | 71.8 |
Investment securities (JPY Bn) | — | — | 374.7 | 393.1 | 369.5 |
Working capital (JPY Bn) | — | — | 390.4 | 388.9 | — |
Book value per share (JPY, split-adjusted) | 2,028.99 | 2,079.23 | 2,433.09 | 2,514.77 | 2,759.42 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansCash Flow
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Operating cash flow (JPY Bn) | 82.0 | 38.0 | 72.6 | 132.7 | 40.4 |
Investing cash flow (JPY Bn) | -39.2 | -25.0 | 18.4 | -36.7 | -73.6 |
Financing cash flow (JPY Bn) | -57.8 | -52.4 | -118.7 | -87.4 | 23.3 |
Capex, tangible plus intangible, CF basis (JPY Bn) | — | — | 74.8 | 72.9 | 73.0 |
Capex, company definition (JPY Bn) | — | — | — | 76.6 | 87.7 |
Free cash flow, OCF minus CF-basis capex (JPY Bn) | — | — | -2.2 | 59.8 | -32.6 |
Share buybacks (JPY Bn) | — | — | 88.6 | 64.9 | 50.8 |
Dividends declared (JPY Bn) | 17.3 | 16.9 | 15.7 | 17.3 | 17.4 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Ratio | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
ROE (%) | 9.1 | 7.9 | 9.8 | 9.6 | 8.9 |
ROA, net profit / average assets (%) | 5.3 | 4.6 | 5.9 | 5.7 | 5.3 |
Ordinary profit / total assets (%) | — | — | — | 6.0 | 6.0 |
Asset turnover (x) | 0.73 | 0.74 | 0.75 | 0.75 | 0.77 |
Current ratio (x) | — | — | 1.95 | 1.89 | — |
Debt / equity (x) | — | — | 0.14 | 0.14 | 0.22 |
Income Statement
| Metric | Q1 FY2024 | Q2 FY2024 | Q3 FY2024 | Q4 FY2024 | Q1 FY2025 | Q2 FY2025 | Q3 FY2025 | Q4 FY2025 | Q1 FY2026 |
|---|---|---|---|---|---|---|---|---|---|
Net sales (JPY Bn) | 356.6 | 351.6 | 370.7 | 378.5 | 366.1 | 372.5 | 389.5 | 384.3 | 372.9 |
Operating profit (JPY Bn) | 18.4 | 19.7 | 24.5 | 30.9 | 22.9 | 23.6 | 29.6 | 24.7 | 27.8 |
Net profit (JPY Bn) | 63.3 | 26.4 | 26.6 | -5.4 | 45.3 | 15.0 | 25.1 | 18.5 | 23.5 |
Revenue by Region and Revenue by Region (%)
| Region | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Japan (JPY Bn) | 1,053.9 | 1,057.4 | 1,089.1 | 1,105.1 | 1,130.4 |
Asia (JPY Bn) | 218.9 | 225.9 | 246.0 | 248.8 | 258.3 |
Other regions (JPY Bn) | 71.3 | 89.9 | 89.7 | 103.7 | 123.9 |
Overseas share of sales (%) | 21.6 | 23.0 | 23.6 | 24.2 | 25.3 |
Region Margins & Growth (%)
| Region | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
Japan growth (%) | 0.3 | 3.0 | 1.5 | 2.3 |
Asia growth (%) | 3.2 | 8.9 | 1.1 | 3.8 |
Other regions growth (%) | 26.0 | -0.2 | 15.6 | 19.4 |
Valuation Snapshot
| Metric | Value |
|---|---|
Share price (TSE, 20 Oct 2026) | ¥2,901.5 |
52-week range | ¥2,435.5 – ¥3,364 |
Market capitalisation | About ¥1.2–1.3 trillion |
Trailing P/E | About 14.8x |
Forward P/E on FY2026 EPS guidance (¥224.24) | About 12.9x |
P/B on March 2026 BPS (¥2,759.42) | About 1.05x |
EV/EBITDA (EV about ¥1.22tn on ¥153.8bn FY2025 EBITDA) | About 7.9x |
EV/Sales | About 0.8x |
Indicated dividend yield | About 1.45% |
Analyst consensus target (5 analysts, Sept 2026) | ¥3,260 |
Per-Share Data and Returns & Leverage Ratios (%)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 plan |
|---|---|---|---|---|---|---|
DPS (JPY, split-adjusted) | 32 | 32 | 32 | 38 | 40 | 41 |
Payout ratio (%) | 18.0 | 19.9 | 14.4 | 15.9 | 17.0 | 18.3 |
Capital Programmes
| Programme | Amount | Status |
|---|---|---|
Five-year programme announced March 2023 | ¥300bn | ¥220bn executed over FY2023–FY2025; remaining ¥80bn scheduled for FY2026–FY2027 |
FY2026 programme (resolved 13 May 2026) | ¥50bn | In progress; ¥4.14bn repurchased in August 2026 |
FY2027 commitment | At least ¥30bn | Planned |
Cancellation | 85,000,000 shares in FY2025 | Completed |
Capital Instruments
| Instrument | Amount (JPY Bn) | Tenor | Maturity |
|---|---|---|---|
7th unsecured bond (Apr 2025) | 40 | 5 years | 2030 |
8th unsecured bond (Apr 2025) | 20 | 7 years | 2032 |
9th unsecured bond (Apr 2025) | 40 | 10 years | 2035 |
Earlier bonds | 100 | Various | Before 2030 |
Bank borrowings, March 2026 (short-term, current and long-term) | 63.6 | Various | Mainly within five years |
Analyst Conclusions
Guidance and consensus
Management guides FY2026 sales to ¥1,530bn (+1.2%), operating profit to ¥108bn (+6.9%) and net profit to ¥95bn (−8.6%). Q1 progress was 25.8% of full-year operating profit guidance. The medium-term plan targets operating profit of ¥120bn in FY2027 and ¥130bn in FY2028, an implied CAGR of about 9%. Consensus estimates compiled in 2026 point to sales of about ¥1.50–1.53 trillion in FY2026–FY2027. Five covering analysts set a consensus target price of ¥3,260 in September 2026, about 12% above the October 2026 price.
Bull case
-
Semiconductor optionality is underpriced. EUV masks for Rapidus (FY2027), 1.4nm NIL templates for Canon (2027) and glass cores (FY2028) could each add meaningful high-margin profit. The plan already has Electronics operating profit rising from ¥50.7bn to ¥65bn.
-
Self-help is proven. Structural reform delivered more than ¥21.5bn of operating profit and beat every target in the 2023 plan. The new plan's ¥130bn target is backed by a further ¥5bn or more of reform benefit and acquisitions (AUSTRIACARD, Kyowa Pharma).
-
Capital returns lift per-share value. ¥80bn of buybacks over two years, cross-shareholding sales and a progressive dividend, all from a net-cash balance sheet, support EPS growth and a re-rating from about 1.05x P/B.
Bear case
-
Earnings quality is falling. Net profit is guided down for a second year to ¥95bn as securities gains fade. ROE is guided at 8.0% in FY2026, which makes 10% by FY2028 hard to reach without asset sales.
-
Cash conversion has weakened. FY2025 operating cash flow of ¥40.4bn did not cover capex, and debt rose to ¥263.6bn. Heavier capex, acquisitions and buybacks could narrow the net cash buffer.
-
Execution and cycle risks are concentrated. The semiconductor upside depends on Rapidus hitting 2027 and on NIL adoption at volume. Meanwhile display and battery-pouch demand has already softened in 2026 because of memory shortages, and a stronger yen would reverse recent tailwinds.
Catalysts and monitorables (next 12 months)
| Timing | Catalyst / monitorable |
|---|---|
| 13 Nov 2026 | Q2 FY2026 results: operating profit progress against ¥108bn guidance, Electronics recovery, buyback pace |
| Q3–Q4 FY2026 | Austrian FDI clearance and AUSTRIACARD closing, squeeze-out and delisting; first consolidation |
| From Q3 FY2026 | Contribution of Kyowa Pharma Chemical (DNP Pharma Chemical) |
| Feb 2027 | Q3 FY2026 results; any guidance revision |
| 2,027 | Rapidus 2nm production ramp and EUV photomask orders; NIL template mass-production start for Canon |
| 2026–2027 | Glass-core sample qualification results and customer wins |
| May 2027 | FY2026 results, FY2027 guidance and confirmation of the ≥¥30bn buyback |
| Ongoing | Operating cash flow recovery; policy shareholding disposals; yen trend; display and memory cycle |
13 Nov 2026: Catalyst / monitorable: Q2 FY2026 results: operating profit progress against ¥108bn guidance, Electronics recovery, buyback pace
Q3–Q4 FY2026: Catalyst / monitorable: Austrian FDI clearance and AUSTRIACARD closing, squeeze-out and delisting; first consolidation
From Q3 FY2026: Catalyst / monitorable: Contribution of Kyowa Pharma Chemical (DNP Pharma Chemical)
Feb 2027: Catalyst / monitorable: Q3 FY2026 results; any guidance revision
2027: Catalyst / monitorable: Rapidus 2nm production ramp and EUV photomask orders; NIL template mass-production start for Canon
2026–2027: Catalyst / monitorable: Glass-core sample qualification results and customer wins
May 2027: Catalyst / monitorable: FY2026 results, FY2027 guidance and confirmation of the ≥¥30bn buyback
Ongoing: Catalyst / monitorable: Operating cash flow recovery; policy shareholding disposals; yen trend; display and memory cycle
Analyst verdict
Dai Nippon Printing is midway through a credible change from a conglomerate trading below book value into a capital-disciplined company led by technology. The evidence is concrete. Operating profit rose from ¥61.2bn in FY2022 to ¥101.0bn in FY2025, beating every interim target. Margins in the reformed Life & Healthcare segment more than doubled. The company retired 85 million shares and still keeps an equity ratio near 58%. Its strategic assets are rare. It is a top-three merchant photomask supplier with EUV capability, it is tied into Japan's 2nm programme as Rapidus's mask partner and investor, and it is the template partner for Canon's nanoimprint lithography. If any of these semiconductor bets reaches volume in 2027–2028, Electronics alone could approach the ¥65bn the plan targets, or exceed it.
The valuation shows that investors are not yet convinced. At about 1.05x book, 13x forward earnings and under 8x EV/EBITDA, the shares price DNP as a mature printer with options attached rather than as a semiconductor materials company. That caution has a basis. Group operating margin is still below 7%. Net profit is guided down again as securities gains fade. FY2025 operating cash flow fell to ¥40.4bn. Electronics has been cyclical, with operating profit down 11.6% in FY2025 and display and battery-pouch softness in 2026. The two acquisitions announced in 2026 (AUSTRIACARD and Kyowa Pharma Chemical) are strategically coherent, but they add integration work while the semiconductor investments are still mostly in development.
The downside is supported by net cash, about ¥370bn of investment securities, a ¥40 minimum dividend and ¥80bn of committed buybacks. The upside comes from semiconductor milestones that will become visible over the next 18 months. The key tests are operating profit at or above ¥108bn in FY2026, a recovery in operating cash flow toward the ¥170bn-a-year pace the plan implies, timely AUSTRIACARD closing, and Rapidus and NIL production starts in 2027. If DNP passes these tests, a re-rating toward 1.3–1.5x book is plausible. Missing them would leave the stock range-bound around book value.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Position | Notes / background | Shareholding (Mar 2026) |
|---|---|---|---|
Yoshinari Kitajima | Representative Director, President | Born 18 Sep 1964 (age 62). Joined Fuji Bank 1987, DNP 1995. Director 2001, Managing Director 2003, Senior Managing Director 2005, Representative Executive VP 2009, President since June 2018. Chairs the Sustainability Committee. AGM approval: 74.6% (2024), 92.2% (2025), 88.9% (2026) | 1,220,868 shares (0.28%) |
Kenji Miya | Representative Director, Executive Vice President | Oversees Smart Communication, Human Capital and Corporate divisions. Chairs the BCM Committee. Representative EVP since June 2024 | 40,240 |
Masafumi Kuroyanagi | Senior Managing Director | Senior executive director | 18,736 |
Kazuhiko Sugita | Senior Managing Director | Senior executive director | 25,336 |
Toru Miyake | Senior Managing Director | Promoted June 2025. Oversees Corporate Communication, IR & PR, Corporate General Affairs. Chairs the Corporate Ethics Committee | 12,722 |
Osamu Nakamura | Senior Managing Director | Promoted from managing executive officer in 2025 | 11,272 |
Minako Miyama | Managing Director | Joined DNP 1986. Head of Human Resources Development and Diversity & Inclusion. Director since 2021. Outside director of Tokai Rika. AGM approval 98.0% (2026) | 13,560 |
Takahito Kanazawa | Managing Director | Executive director | 7,994 |
Tsukasa Miyajima | Outside Director | Independent | — |
Yoshiaki Tamura | Outside Director | Independent | — |
Hiroshi Shirakawa | Outside Director | Independent | — |
Nobuhiko Sugiura | Outside Director | Independent | — |
Mika Kumahira | Outside Director | Head of Showa Women's University Career College. Joined June 2025 | — |
Shigeki Fujita | Outside Director | Former President & Representative Director of Shibaura Mechatronics. Joined June 2026; adds semiconductor-equipment expertise | — |
Executive Leadership Team
| Name | Role |
|---|---|
Naoki Wakabayashi | Head of IR & Public Relations Division |
Yusuke Tezuka | General Manager, Financial Strategy Department |
Nobuaki Kanayama | Executive Officer (from June 2026); Head of R&D and Business Development Center |
Kozo Odamura | Executive Officer (from June 2026); Deputy Head, Imaging Communication Operations |
Takayuki Moriya | Executive Officer (from June 2026); Deputy Head, Information Innovation Operations |
Sakae Hikita | Retired as Senior Managing Executive Officer in June 2026; now adviser |
Governance Detail
| Category | Number | Total (JPY Mn) | Average per person (JPY Mn) |
|---|---|---|---|
Directors (excluding outside) | 9 | 727 | 80.8 |
Corporate auditors (excluding outside) | 2 | 60 | 30.0 |
Outside officers | 8 | 138 | 17.3 |
Total | 19 | 925 | — |
Individual | FY2023 (JPY m) | FY2024 (JPY m) | FY2025 (JPY m) |
Yoshinari Kitajima, President | 255 | 268 | 284 |
Kenji Miya, Representative EVP | — | — | 105 |
Major Shareholders
| Rank | Shareholder | Shares (thousand) | Stake (%) |
|---|---|---|---|
| 1 | The Master Trust Bank of Japan, Ltd. (trust account) | 75,183 | 17.43 |
| 2 | Custody Bank of Japan, Ltd. (trust account) | 24,254 | 5.62 |
| 3 | State Street Bank and Trust Company 505001 | 13,233 | 3.07 |
| 4 | DNP Employee Shareholding Association | 12,441 | 2.88 |
| 5 | The Dai-ichi Life Insurance Company, Limited | 11,923 | 2.76 |
| 6 | Nippon Life Insurance Company | 9,471 | 2.20 |
| 7 | Mizuho Bank, Ltd. | 7,666 | 1.78 |
| 8 | Government of Norway | 5,903 | 1.37 |
| 9 | JPMorgan Chase Bank (custody account) | 5,739 | 1.33 |
| 10 | JPMorgan Securities Japan | 5,048 | 1.17 |
Competitive Landscape
Competitors by Segment
| Business | Principal competitors | DNP's relative position |
|---|---|---|
Merchant photomasks | Tekscend Photomask (spun off from TOPPAN, TSE-listed October 2025), Photronics (US), Taiwan Mask, SK-Electronics, Hoya (mask blanks and masks), Shenzhen Qingyi; captive mask shops at TSMC, Samsung and Intel | One of the three largest merchant suppliers. Differentiated by early MBMW adoption, EUV capability and the Rapidus relationship |
Nanoimprint templates | Few merchant alternatives; captive development at tool and device makers | Primary template partner for Canon's NIL tools |
Glass-core substrates | Absolics (SKC), Samsung Electro-Mechanics, LG Innotek, Shinko Electric, Ibiden, TOPPAN, Intel (in-house), Rapidus (in-house panel packaging) | Pilot stage, aiming for FY2028 mass production; competitors target 2027–2028 |
OLED fine metal masks | TOPPAN, emerging Chinese and Korean suppliers | Leading supplier of etched FMMs |
Display optical films | Nitto Denko, Sumitomo Chemical, Fujifilm, TOPPAN | Specialist in anti-reflection/anti-glare coatings |
IC cards and secure ID | TOPPAN, IDEMIA, Thales, Giesecke+Devrient, AUSTRIACARD (being acquired) | Leading Japanese supplier; expanding globally through AUSTRIACARD |
Photo-imaging media | Mitsubishi Electric, Citizen, HiTi, Sony (legacy) | Leading global dye-sublimation media supplier |
Commercial printing and BPO | TOPPAN, Kyodo Printing, Toppan Edge, Recruit (BPO) | Number two in Japanese printing |
Packaging | TOPPAN, Rengo, Fuji Seal, Amcor (global) | Major domestic converter |
Battery pouches | Resonac Packaging, Youlchon Chemical, TOPPAN (former) | Leading global supplier |
Peer Comparison FY2025
| Metric | DNP (FY2025, Mar 2026) | TOPPAN Holdings (FY2025, Mar 2026) | Photronics (FY2025, Oct 2025) |
|---|---|---|---|
Revenue | ¥1,512.6bn | ¥1,805.0bn | US$849.3m |
Revenue growth (%) | 3.8 | 5.1 | -2.0 |
Operating profit | ¥101.0bn | ¥67.1bn | US$208.2m |
Operating margin (%) | 6.7 | 3.7 | 24.5 |
Net profit | ¥104.0bn | ¥64.8bn | US$136.4m |
